Eventos

Discriminar os critérios que definem a Perturbação de Luto Prolongado e abordar conceções incorretas que envolvem o luto são alguns dos temas abordados pela Professora Holly G. Prigerson da Universidade de Cornell (EUA), na conferência “Prolonged Grief Disorder & Approaches to EMPOWERment”, no dia 23 de fevereiro, às 12h, na Sala de Atos do Ispa.

Entrada livre.

Nesta conferência, aborda-se a Perturbação de Luto Prolongado (PGD). Iniciamos com uma compreensão do percurso do luto típico e atípico (prolongado), destrinçando os critérios que definem o PGD e examinando potenciais diagnósticos diferenciais. Abordamos conceções incorretas, mas comuns, em torno do luto, abrindo caminho para uma compreensão mais clara desta experiência emocional complexa.
Na conferência, apresentamos uma nova teoria microsociológica que lança luz sobre os processos de adaptação à perda, enfatizando o papel de fatores sociais no processo de luto. A apresentação culmina numa discussão das implicações do tratamento, destacando a intervenção EMPOWER. Analisamos os componentes-chave do EMPOWER e exploramos a sua eficácia na promoção da recuperação e resiliência. Adicionalmente, exploramos o papel de intervenções online para oferecer apoio acessível e eficaz a indivíduos lidando com o PGD. Em conjunto, estas perceções contribuem para uma compreensão global do Luto Prolongado e oferecem abordagens variadas para o seu tratamento.

Biografia

Holly G. Prigerson, PhD, is the Irving Sherwood Wright Professor of Geriatrics at Weill Cornell Medicine (WCM), and Co-Director of the Cornell Center for Research on End-of-Life Care. She was approved for tenure at Yale, Harvard, and Weill Cornell Medicine, and has served as PI on numerous NIH investigations, including the main studies that justified the inclusion of Prolonged Grief Disorder in ICD-11 and DSM-5-TR and which have examined psychosocial influences on and outcomes of end-of-life care.She received the Harvard Medical School’s (HMS) Clifford Barger Excellence in Mentoring Award, was a founding member of the HMS Council of Mentors, was the 2012 NHPCO’s Distinguished Researcher Award, the NCI’s R35 Outstanding Investigator Award, and the 2018 AAHPM award for excellence in scientific research in palliative medicine. In 2022 her NCI Outstanding Investigator Award was renewed for another 7-year period (amounting to NCI $14 million investment in select scientists to have freedom and security to pursue their research agenda). This award supports her research program on end-of-life cancer care. It also supports her development of psychosocial and behavioral resources and interventions to reduce suffering among patients confronting life-threatening illnesses and death as well as for those who care most for, and ultimately, survive them. As of 2024, her H-Index was 112, with over 400 publications, most in leading medical journals. She has mentored approximately 100 trainees to successful careers in medicine and healthcare research and received over 80 grants from the NIH including 6 currently (please see below), and three R01s pending award. Her contributions to medical research, mentoring physician scientists, and advancing end-of-life research remain on a steep upward trajectory.